Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201201081 Principal Investigator: Mutch, David
Title: A Randomized Double-Blind Phase 3 Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil/Caelyx) in Combination versus PLD in Participants with Platinum-Resistant Ovarian Cancer
Phase: III Disease Site: Ovary
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test the effects of EC145 in combination with Doxil®/Caelyx® good or bad, in women with platinum-resistant ovarian cancer. We also want to test the safety of EC145 in combination with Doxil®/Caelyx®.
 
More Information:
CT.gov link
Internal Protocol Documents (requires Siteman administrative database password)